These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29057672)

  • 1. Chemical meningitis related to intra-CSF liposomal cytarabine.
    Durand B; Zairi F; Boulanger T; Bonneterre J; Mortier L; Le Rhun E
    CNS Oncol; 2017 Oct; 6(4):261-267. PubMed ID: 29057672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
    Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
    Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulminant chemical ventriculomeningitis following intrathecal liposomal cytarabine administration.
    Butto A; Al-Holou WN; Junck L; Sagher O; Fletcher JJ
    J Clin Neurosci; 2011 Oct; 18(10):1417-8. PubMed ID: 21764318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis.
    Benesch M; Sovinz P; Krammer B; Lackner H; Mann G; Schwinger W; Gadner H; Urban C
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):222-6. PubMed ID: 17414563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study.
    Scott BJ; van Vugt VA; Rush T; Brown T; Chen CC; Carter BS; Schwab R; Fanta P; Helsten T; Bazhenova L; Parker B; Pingle S; Saria MG; Brown BD; Piccioni DE; Kesari S
    J Neurooncol; 2014 Sep; 119(2):361-8. PubMed ID: 24942463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series.
    Chamberlain MC
    J Neurooncol; 2012 Aug; 109(1):143-8. PubMed ID: 22539243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report.
    Gaviani P; Silvani A; Corsini E; Erbetta A; Salmaggi A
    Neurol Sci; 2009 Jun; 30(3):251-4. PubMed ID: 19259616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study.
    Fusco JP; Castañón E; Carranza OE; Zubiri L; Martín P; Espinós J; Rodríguez J; Santisteban M; Aramendía JM; Gil-Bazo I
    J Neurooncol; 2013 Dec; 115(3):429-35. PubMed ID: 24037499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis.
    Glantz MJ; Van Horn A; Fisher R; Chamberlain MC
    Cancer; 2010 Apr; 116(8):1947-52. PubMed ID: 20151421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.
    Bomgaars L; Geyer JR; Franklin J; Dahl G; Park J; Winick NJ; Klenke R; Berg SL; Blaney SM
    J Clin Oncol; 2004 Oct; 22(19):3916-21. PubMed ID: 15459213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis.
    Jahn F; Jordan K; Behlendorf T; Globig C; Schmoll HJ; Müller-Tidow C; Jordan B
    Oncology; 2015; 89(3):137-42. PubMed ID: 25791073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine.
    Bohn JP; Reinstadler V; Pall G; Stockhammer G; Steurer M; Oberacher H; Wolf D
    Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):845-851. PubMed ID: 31435852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients.
    Zairi F; Le Rhun E; Bertrand N; Boulanger T; Taillibert S; Aboukais R; Assaker R; Chamberlain MC
    J Neurooncol; 2015 Sep; 124(2):317-23. PubMed ID: 26070555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of liposomal cytarabine in neoplastic meningitis].
    Rudà R; Leoncini B; Laguzzi E; Trevisan E; Guarneri D; Bertetto O; Soffietti R
    Tumori; 2007; 93(3):suppl 4-5. PubMed ID: 17679479
    [No Abstract]   [Full Text] [Related]  

  • 16. A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer.
    Le Rhun E; Taillibert S; Zairi F; Kotecki N; Devos P; Mailliez A; Servent V; Vanlemmens L; Vennin P; Boulanger T; Baranzelli MC; André C; Marliot G; Cazin JL; Dubois F; Assaker R; Bonneterre J; Chamberlain MC
    J Neurooncol; 2013 May; 113(1):83-92. PubMed ID: 23456656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study.
    Phuphanich S; Maria B; Braeckman R; Chamberlain M
    J Neurooncol; 2007 Jan; 81(2):201-8. PubMed ID: 16941075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis.
    Rueda Domínguez A; Olmos Hidalgo D; Viciana Garrido R; Torres Sánchez E
    Clin Transl Oncol; 2005 Jul; 7(6):232-8. PubMed ID: 16131445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
    Brion A; Legrand F; Larosa F; Schillinger F; Garnache-Ottou F; Helias P; Fontan J; Heczko M; Delaby P; Daguindau E; Vuillier J; Chauchet A; Deconinck E
    Invest New Drugs; 2012 Aug; 30(4):1697-702. PubMed ID: 21229289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.
    Hilgendorf I; Wolff D; Junghanss C; Kahl C; Leithaeuser M; Steiner B; Casper J; Freund M
    Ann Hematol; 2008 Dec; 87(12):1009-12. PubMed ID: 18704421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.